<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:f9eb3e20-957c-4f50-8702-b49f6cfda7cd,g:65c41fe5-7b76-4628-b8ad-1845793955b0-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://arbutusbio.com/role/Cover" xlink:type="simple" xlink:href="abus-20220331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_da6cb6e4-8bc7-46c0-88d0-66491d7deb50" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentType_da6cb6e4-8bc7-46c0-88d0-66491d7deb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d507bd36-5333-4942-8b65-727b3ae43db1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentQuarterlyReport_d507bd36-5333-4942-8b65-727b3ae43db1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_70754cec-3a87-4a2d-8ab3-4ad94da6d2e4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentPeriodEndDate_70754cec-3a87-4a2d-8ab3-4ad94da6d2e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_7c32a07a-db35-4615-8ae9-4eea0002cd29" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentTransitionReport_7c32a07a-db35-4615-8ae9-4eea0002cd29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_8575341e-8357-49ff-a67e-4cf635ececce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityFileNumber_8575341e-8357-49ff-a67e-4cf635ececce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_4b47c5fb-33f1-41b9-9181-3c21f9366696" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityRegistrantName_4b47c5fb-33f1-41b9-9181-3c21f9366696" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_1183f646-0542-46a3-809b-0ff8994c89d2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityIncorporationStateCountryCode_1183f646-0542-46a3-809b-0ff8994c89d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_82345c33-001b-4b6c-a367-4c7d2fdc5965" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityTaxIdentificationNumber_82345c33-001b-4b6c-a367-4c7d2fdc5965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_ad8a390f-6c5a-4481-a000-c03eeb040c68" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityAddressAddressLine1_ad8a390f-6c5a-4481-a000-c03eeb040c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_855bf064-d23e-44da-8d6d-34d4b06f117b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityAddressCityOrTown_855bf064-d23e-44da-8d6d-34d4b06f117b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_51edaf21-fd29-4ba8-a61e-949be55d653e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityAddressStateOrProvince_51edaf21-fd29-4ba8-a61e-949be55d653e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_b9ae1931-6360-48ac-937d-b24478dd7a1f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityAddressPostalZipCode_b9ae1931-6360-48ac-937d-b24478dd7a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b522a3f6-e099-418c-924b-5da9631e3e18" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_CityAreaCode_b522a3f6-e099-418c-924b-5da9631e3e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_f0a2070d-a03b-403b-bdf0-92ade9c5c265" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_LocalPhoneNumber_f0a2070d-a03b-403b-bdf0-92ade9c5c265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_539d4b62-de92-4001-8d72-a1de3d316588" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_Security12bTitle_539d4b62-de92-4001-8d72-a1de3d316588" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_c4a026b2-7261-46bb-a873-1da65bd914cb" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_TradingSymbol_c4a026b2-7261-46bb-a873-1da65bd914cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0c1243d1-0162-4575-8949-5093e36d0bed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_SecurityExchangeName_0c1243d1-0162-4575-8949-5093e36d0bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_3c240b13-7eaf-4b97-9b94-6a87cdc7c4ed" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityCurrentReportingStatus_3c240b13-7eaf-4b97-9b94-6a87cdc7c4ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_00d4a745-9a2c-43d2-aa9b-1c41405dfe13" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityInteractiveDataCurrent_00d4a745-9a2c-43d2-aa9b-1c41405dfe13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_794436a3-2728-4abd-879b-fc657f1e26ac" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityFilerCategory_794436a3-2728-4abd-879b-fc657f1e26ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_ed755386-564a-41aa-aced-beb093bd1fa3" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntitySmallBusiness_ed755386-564a-41aa-aced-beb093bd1fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_4bb94075-ce96-49c8-950d-9b8e02af7c3e" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityEmergingGrowthCompany_4bb94075-ce96-49c8-950d-9b8e02af7c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_92f76274-9b7a-4b18-9a28-c2ea5994f8ab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityShellCompany_92f76274-9b7a-4b18-9a28-c2ea5994f8ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_efd2bf73-822e-4995-8a70-901c028d4d42" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_efd2bf73-822e-4995-8a70-901c028d4d42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_f79e1b12-8b16-4bca-9128-f25395aadeda" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_AmendmentFlag_f79e1b12-8b16-4bca-9128-f25395aadeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_39913064-5ad7-44e9-a305-473663362c50" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_EntityCentralIndexKey_39913064-5ad7-44e9-a305-473663362c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_11c0c030-6ac0-4e9c-8ad6-6a25adcec44b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_CurrentFiscalYearEndDate_11c0c030-6ac0-4e9c-8ad6-6a25adcec44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3dd63daf-e55a-4123-9e84-85e6172b22d9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentFiscalYearFocus_3dd63daf-e55a-4123-9e84-85e6172b22d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_44097706-1ed6-4a57-a5b8-eb716c2ccb6b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_b23c0cc6-60fc-4e19-b03e-c4e574216a04" xlink:to="loc_dei_DocumentFiscalPeriodFocus_44097706-1ed6-4a57-a5b8-eb716c2ccb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="simple" xlink:href="abus-20220331.xsd#CondensedConsolidatedBalanceSheetsUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d4482d6a-09c3-4f3d-bce4-247e2d276824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4482d6a-09c3-4f3d-bce4-247e2d276824" xlink:to="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d344edd6-54d6-41ce-a8b9-4c45a6342e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_d344edd6-54d6-41ce-a8b9-4c45a6342e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b7b5d13d-92ca-4f56-ac16-b892477364bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_b7b5d13d-92ca-4f56-ac16-b892477364bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_11e87fa0-adef-4d75-a09a-c0f3454d933d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_11e87fa0-adef-4d75-a09a-c0f3454d933d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b1d8d6a-cb11-4457-bb9d-35d09710c7b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_5b1d8d6a-cb11-4457-bb9d-35d09710c7b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_1f96aea8-4c34-41bf-bcd8-564faa045b99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_455e17fd-7e4d-4293-8c41-7866786a8b4f" xlink:to="loc_us-gaap_AssetsCurrent_1f96aea8-4c34-41bf-bcd8-564faa045b99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_0ea3d761-2b0a-4037-bb17-1648446c3a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_0ea3d761-2b0a-4037-bb17-1648446c3a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_0080cbcf-c0ab-4211-81cb-a630c4a0ad6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_LongTermInvestments_0080cbcf-c0ab-4211-81cb-a630c4a0ad6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfbf2c46-2643-4ef1-8920-f3afa6fae853" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_bfbf2c46-2643-4ef1-8920-f3afa6fae853" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_25f38895-0b1e-4a23-829f-979e91cc16d2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_25f38895-0b1e-4a23-829f-979e91cc16d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_8efcc150-e3b5-4307-a813-3a1196705327" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_6aadfe92-b99f-43fa-9384-c5b111c63929" xlink:to="loc_us-gaap_Assets_8efcc150-e3b5-4307-a813-3a1196705327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d4482d6a-09c3-4f3d-bce4-247e2d276824" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fd46871f-1815-40ee-9b49-b2e7402e728d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_fd46871f-1815-40ee-9b49-b2e7402e728d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_bc64daab-d022-4277-87c1-3c74d58fab36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:to="loc_us-gaap_DeferredRevenueCurrent_bc64daab-d022-4277-87c1-3c74d58fab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_bac8167b-66bb-4a79-a756-f09d07e14c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_bac8167b-66bb-4a79-a756-f09d07e14c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2b84b0b0-643d-49da-8730-c89a52d2ddb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1a74e95b-8e38-4d23-a080-0148bed6bccb" xlink:to="loc_us-gaap_LiabilitiesCurrent_2b84b0b0-643d-49da-8730-c89a52d2ddb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_5dbbb339-e4cf-4171-92dc-492e88352c37" xlink:href="abus-20220331.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_5dbbb339-e4cf-4171-92dc-492e88352c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_efae9f27-a86b-4b41-b842-326ac7498d14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_efae9f27-a86b-4b41-b842-326ac7498d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_18f6fc9b-dad3-4f2b-9fad-a23abb05a13d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_18f6fc9b-dad3-4f2b-9fad-a23abb05a13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84ab0667-6bea-4215-b308-7e1d9620945c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_84ab0667-6bea-4215-b308-7e1d9620945c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_966467e2-3bd8-45f0-8b4f-16d9a4437181" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_Liabilities_966467e2-3bd8-45f0-8b4f-16d9a4437181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_9e52df69-d3e8-454c-bdf1-f707fece14ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:to="loc_us-gaap_CommonStockValue_9e52df69-d3e8-454c-bdf1-f707fece14ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a34a29ba-a648-4c45-bbfc-14bb046bb9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a34a29ba-a648-4c45-bbfc-14bb046bb9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32cd1221-de3c-4b55-a3fc-05e4a8a06e91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_32cd1221-de3c-4b55-a3fc-05e4a8a06e91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2781f594-6500-4b39-9f35-1ffd9d4920ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2781f594-6500-4b39-9f35-1ffd9d4920ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f8dc8747-4cc4-4542-9aa2-4ef04c984f1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_c1347334-201b-4528-8345-2fea015eb63d" xlink:to="loc_us-gaap_StockholdersEquity_f8dc8747-4cc4-4542-9aa2-4ef04c984f1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_af7e689c-caa2-43df-aeaf-3a46b97484ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b757efc5-9745-48e7-8e19-1dd46483d1d6" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_af7e689c-caa2-43df-aeaf-3a46b97484ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="simple" xlink:href="abus-20220331.xsd#CondensedConsolidatedBalanceSheetsUnauditedParenthetical"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedBalanceSheetsUnauditedParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_98ef17ca-fa08-4515-8c08-357b9657d54a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7bff3eb6-4f58-437d-a9be-7961519a60c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_98ef17ca-fa08-4515-8c08-357b9657d54a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7bff3eb6-4f58-437d-a9be-7961519a60c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a37ef784-9823-4f13-a4c0-dc64b0065af0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_98ef17ca-fa08-4515-8c08-357b9657d54a" xlink:to="loc_us-gaap_CommonStockSharesIssued_a37ef784-9823-4f13-a4c0-dc64b0065af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f1a69662-7636-419a-bc60-e373f7ae5068" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_98ef17ca-fa08-4515-8c08-357b9657d54a" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f1a69662-7636-419a-bc60-e373f7ae5068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="simple" xlink:href="abus-20220331.xsd#CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementsofOperationsandComprehensiveLossUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_aff48ff9-f438-403a-bb19-354bdd2769c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e3de5b49-3180-4122-aef9-8d9803b7e4c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_aff48ff9-f438-403a-bb19-354bdd2769c7" xlink:to="loc_us-gaap_StatementTable_e3de5b49-3180-4122-aef9-8d9803b7e4c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_aefa9ba3-2f24-4fca-94bc-cf7130580b08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3de5b49-3180-4122-aef9-8d9803b7e4c6" xlink:to="loc_srt_ProductOrServiceAxis_aefa9ba3-2f24-4fca-94bc-cf7130580b08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_9edde381-2c2f-4bd0-94f0-9e34d0d8516d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_aefa9ba3-2f24-4fca-94bc-cf7130580b08" xlink:to="loc_srt_ProductsAndServicesDomain_9edde381-2c2f-4bd0-94f0-9e34d0d8516d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_CollaborationAndContractsMember_09910896-350a-48c5-8e33-60700312064a" xlink:href="abus-20220331.xsd#abus_CollaborationAndContractsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9edde381-2c2f-4bd0-94f0-9e34d0d8516d" xlink:to="loc_abus_CollaborationAndContractsMember_09910896-350a-48c5-8e33-60700312064a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_a1c26c00-7601-4347-88ae-781936786368" xlink:href="abus-20220331.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_9edde381-2c2f-4bd0-94f0-9e34d0d8516d" xlink:to="loc_abus_NonCashRoyaltyMember_a1c26c00-7601-4347-88ae-781936786368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_bc988c5e-d05f-4cb8-a34b-9f5dd309b88c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3de5b49-3180-4122-aef9-8d9803b7e4c6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_bc988c5e-d05f-4cb8-a34b-9f5dd309b88c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_9e71214e-2652-4833-805f-e3ca32e23646" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_bc988c5e-d05f-4cb8-a34b-9f5dd309b88c" xlink:to="loc_us-gaap_EquityComponentDomain_9e71214e-2652-4833-805f-e3ca32e23646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e3de5b49-3180-4122-aef9-8d9803b7e4c6" xlink:to="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_ba50485b-9e92-427a-9ee7-6df1300c2e4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_RevenuesAbstract_ba50485b-9e92-427a-9ee7-6df1300c2e4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_d3a7c8c9-e806-4034-a06e-bfb8cae3b887" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_ba50485b-9e92-427a-9ee7-6df1300c2e4f" xlink:to="loc_us-gaap_Revenues_d3a7c8c9-e806-4034-a06e-bfb8cae3b887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_84725f38-ad26-4480-b89b-e9768f2c86a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_84725f38-ad26-4480-b89b-e9768f2c86a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_81996091-fbff-4c39-9b5a-91c98e5e3a31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_81996091-fbff-4c39-9b5a-91c98e5e3a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_8dc183aa-ef9a-4def-8665-d8c8375d1ec0" xlink:href="abus-20220331.xsd#abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:to="loc_abus_IncreaseDecreaseInFairValueOfContingentConsiderationLiability_8dc183aa-ef9a-4def-8665-d8c8375d1ec0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_40f789d2-e660-4f6f-b5e5-7d5b2904398c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_95bc70bd-5a2a-4d6e-ab2e-b49ed2e5dee1" xlink:to="loc_us-gaap_OperatingExpenses_40f789d2-e660-4f6f-b5e5-7d5b2904398c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_1c649f77-a15f-4014-8a3a-271363944680" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_OperatingIncomeLoss_1c649f77-a15f-4014-8a3a-271363944680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_9fbc77d8-e239-48f5-9d30-d7c1f7c15aae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_InvestmentIncomeInterest_9fbc77d8-e239-48f5-9d30-d7c1f7c15aae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f9f8b9bf-8fd8-486b-8e88-d4f2d693cd99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_InterestExpense_f9f8b9bf-8fd8-486b-8e88-d4f2d693cd99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_18d8a5ab-5e52-4316-8eb5-22489fec5412" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_18d8a5ab-5e52-4316-8eb5-22489fec5412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_d0b9ef25-1574-4a27-9919-94581d38631f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_d0b9ef25-1574-4a27-9919-94581d38631f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b375ca1-9a00-4cc1-bb19-ba9066d86a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2b375ca1-9a00-4cc1-bb19-ba9066d86a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f157c48f-23af-4e01-ad02-5d79d5dd3a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_NetIncomeLoss_f157c48f-23af-4e01-ad02-5d79d5dd3a37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_3ba6c7ef-a2f0-4a8d-9c1e-630c9ae5af7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_3ba6c7ef-a2f0-4a8d-9c1e-630c9ae5af7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_e8624820-90bb-4e00-be22-ecfe3bd92816" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendsAndOtherAdjustments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PreferredStockDividendsAndOtherAdjustmentsAbstract_3ba6c7ef-a2f0-4a8d-9c1e-630c9ae5af7f" xlink:to="loc_us-gaap_PreferredStockDividendsAndOtherAdjustments_e8624820-90bb-4e00-be22-ecfe3bd92816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7e8d699-b612-4c49-a5a9-719f33f39ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e7e8d699-b612-4c49-a5a9-719f33f39ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_7344ed57-1d0d-4e9e-a9f9-bbecc43da013" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_EarningsPerShareAbstract_7344ed57-1d0d-4e9e-a9f9-bbecc43da013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_202f12c6-99ea-4504-8373-60efff6ff3ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7344ed57-1d0d-4e9e-a9f9-bbecc43da013" xlink:to="loc_us-gaap_EarningsPerShareBasic_202f12c6-99ea-4504-8373-60efff6ff3ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_93ab536d-edc4-455a-968c-cd86a2b888bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_7344ed57-1d0d-4e9e-a9f9-bbecc43da013" xlink:to="loc_us-gaap_EarningsPerShareDiluted_93ab536d-edc4-455a-968c-cd86a2b888bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_576515b8-91ab-4b4c-b118-f9dd960683e3" xlink:href="abus-20220331.xsd#abus_WeightedAverageNumberOfCommonSharesAbstract"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_576515b8-91ab-4b4c-b118-f9dd960683e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee1e3759-93e9-45e1-bb05-4ef0726355ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_576515b8-91ab-4b4c-b118-f9dd960683e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ee1e3759-93e9-45e1-bb05-4ef0726355ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a48bc76-cbd7-4651-b211-f19abbcf92f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_WeightedAverageNumberOfCommonSharesAbstract_576515b8-91ab-4b4c-b118-f9dd960683e3" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_5a48bc76-cbd7-4651-b211-f19abbcf92f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2c39598a-9357-4442-a468-bbef11e9a299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTaxAbstract"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2c39598a-9357-4442-a468-bbef11e9a299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_7a9f05c2-b7d4-4b92-9252-702279aa3782" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2c39598a-9357-4442-a468-bbef11e9a299" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedGainLoss_7a9f05c2-b7d4-4b92-9252-702279aa3782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_42bcf901-f50e-4180-b777-3bc2673900ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTaxAbstract_2c39598a-9357-4442-a468-bbef11e9a299" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_42bcf901-f50e-4180-b777-3bc2673900ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_430bcb07-9ab8-4d70-b56e-0fa757295c91" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_d282f862-e82b-4757-80e0-37415159ec7a" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_430bcb07-9ab8-4d70-b56e-0fa757295c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementofStockholdersEquityUnaudited" xlink:type="simple" xlink:href="abus-20220331.xsd#CondensedConsolidatedStatementofStockholdersEquityUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementofStockholdersEquityUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_c1ab69e4-25c4-443b-9286-cec83bd2c7c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_21992dfa-b71e-4f02-b09b-f663e469636f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_c1ab69e4-25c4-443b-9286-cec83bd2c7c3" xlink:to="loc_us-gaap_StatementTable_21992dfa-b71e-4f02-b09b-f663e469636f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_25b12428-d3d0-4ece-a907-579042772e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21992dfa-b71e-4f02-b09b-f663e469636f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_25b12428-d3d0-4ece-a907-579042772e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_25b12428-d3d0-4ece-a907-579042772e32" xlink:to="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_58f108e0-7dc4-4b8d-a66d-02b70403c80d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:to="loc_us-gaap_CommonStockMember_58f108e0-7dc4-4b8d-a66d-02b70403c80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_14954f7c-7a77-4b41-867b-39e2909ffe81" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_14954f7c-7a77-4b41-867b-39e2909ffe81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1ab922a0-7286-42b0-b26c-ed0b183d9222" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:to="loc_us-gaap_RetainedEarningsMember_1ab922a0-7286-42b0-b26c-ed0b183d9222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8745337-8590-4763-a123-2d67ca3b9d13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a8745337-8590-4763-a123-2d67ca3b9d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockMember_cedd5327-ceb2-4bad-96a0-3b1201bb7852" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_933a4f37-c23c-4281-955f-2afddf63814e" xlink:to="loc_us-gaap_PreferredStockMember_cedd5327-ceb2-4bad-96a0-3b1201bb7852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2d68ee02-474f-46e1-bcd8-7d183291dcf7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21992dfa-b71e-4f02-b09b-f663e469636f" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2d68ee02-474f-46e1-bcd8-7d183291dcf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_67a1b280-678e-42ee-b1a5-631ac677c757" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2d68ee02-474f-46e1-bcd8-7d183291dcf7" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_67a1b280-678e-42ee-b1a5-631ac677c757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_e50beb34-def3-40d2-96f3-10392e45fbf9" xlink:href="abus-20220331.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_67a1b280-678e-42ee-b1a5-631ac677c757" xlink:to="loc_abus_OpenMarketSaleAgreementMember_e50beb34-def3-40d2-96f3-10392e45fbf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharePurchaseAgreementMember_fb5ce655-2d36-46c5-91e6-04204f31dd1e" xlink:href="abus-20220331.xsd#abus_SharePurchaseAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_67a1b280-678e-42ee-b1a5-631ac677c757" xlink:to="loc_abus_SharePurchaseAgreementMember_fb5ce655-2d36-46c5-91e6-04204f31dd1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2207ddd8-9f3d-4f47-9e5b-16b8e4cb4ded" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_21992dfa-b71e-4f02-b09b-f663e469636f" xlink:to="loc_us-gaap_StatementLineItems_2207ddd8-9f3d-4f47-9e5b-16b8e4cb4ded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2207ddd8-9f3d-4f47-9e5b-16b8e4cb4ded" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6e43bf03-19ef-49c8-96ad-172cb6ebd76d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_SharesIssued_6e43bf03-19ef-49c8-96ad-172cb6ebd76d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7640f81a-3972-4193-987f-c141c6cffdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockholdersEquity_7640f81a-3972-4193-987f-c141c6cffdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_c95150dd-6b30-44e7-9c13-0b3835ba0779" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockAccretionOfRedemptionDiscount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_PreferredStockAccretionOfRedemptionDiscount_c95150dd-6b30-44e7-9c13-0b3835ba0779" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7a6bb10b-26e4-48ad-9505-ccf28da77b1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_7a6bb10b-26e4-48ad-9505-ccf28da77b1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_cf7e1d66-d49c-4331-b5bd-4e58e5d97dcf" xlink:href="abus-20220331.xsd#abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_abus_AdjustmentstoAdditionalPaidinCapitalCertainFairValueAdjustmentstoLiabilityStockOptionAwards_cf7e1d66-d49c-4331-b5bd-4e58e5d97dcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9af8a5f7-a97a-4875-ba1d-8ecf3349d618" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_9af8a5f7-a97a-4875-ba1d-8ecf3349d618" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fcd4cdc9-a223-4a83-955b-72263c770ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_fcd4cdc9-a223-4a83-955b-72263c770ae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a28cc66-e5d1-4e81-8e7a-c108540aae75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0a28cc66-e5d1-4e81-8e7a-c108540aae75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f355e941-bc2a-49cc-99c2-f3aca169440f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_f355e941-bc2a-49cc-99c2-f3aca169440f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_db0b25db-12d3-4c05-89ab-858251d2a5e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_db0b25db-12d3-4c05-89ab-858251d2a5e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_542729b2-9d40-434b-9f02-abf24b8605d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_542729b2-9d40-434b-9f02-abf24b8605d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6950a51a-4976-4aa3-a58d-01fe9860e1fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_6950a51a-4976-4aa3-a58d-01fe9860e1fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_beb75632-bbcb-4b44-9461-826e2a65db9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_NetIncomeLoss_beb75632-bbcb-4b44-9461-826e2a65db9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_77954b4a-4bbc-4725-8b68-9073b038abcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_SharesIssued_77954b4a-4bbc-4725-8b68-9073b038abcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_d537a891-13d0-49a7-99b8-0c0d8b5cd09e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_5c56f2f5-6a69-4a32-9369-aa0011c51125" xlink:to="loc_us-gaap_StockholdersEquity_d537a891-13d0-49a7-99b8-0c0d8b5cd09e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CondensedConsolidatedStatementsofCashFlowUnaudited" xlink:type="simple" xlink:href="abus-20220331.xsd#CondensedConsolidatedStatementsofCashFlowUnaudited"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CondensedConsolidatedStatementsofCashFlowUnaudited" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_721ef937-964a-4877-9c0a-8d25d45b44c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_d8966f47-3683-4d1d-b161-8f475fb66257" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_721ef937-964a-4877-9c0a-8d25d45b44c4" xlink:to="loc_us-gaap_StatementTable_d8966f47-3683-4d1d-b161-8f475fb66257" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_aa4bf517-1c35-4c7d-9a6a-e698b07f69cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8966f47-3683-4d1d-b161-8f475fb66257" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_aa4bf517-1c35-4c7d-9a6a-e698b07f69cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2698eb1-966c-48a9-90d1-feff16e5cb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_aa4bf517-1c35-4c7d-9a6a-e698b07f69cd" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2698eb1-966c-48a9-90d1-feff16e5cb6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharePurchaseAgreementMember_dccf8b50-1c7c-4ca9-bfd8-8ddfc03a014b" xlink:href="abus-20220331.xsd#abus_SharePurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2698eb1-966c-48a9-90d1-feff16e5cb6e" xlink:to="loc_abus_SharePurchaseAgreementMember_dccf8b50-1c7c-4ca9-bfd8-8ddfc03a014b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OpenMarketSaleAgreementMember_03ef7fad-a774-4d10-9c86-4b17f25f4108" xlink:href="abus-20220331.xsd#abus_OpenMarketSaleAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e2698eb1-966c-48a9-90d1-feff16e5cb6e" xlink:to="loc_abus_OpenMarketSaleAgreementMember_03ef7fad-a774-4d10-9c86-4b17f25f4108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_d8966f47-3683-4d1d-b161-8f475fb66257" xlink:to="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1ec6df8e-1ee4-4531-8b28-63d57d251eda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:to="loc_us-gaap_NetIncomeLoss_1ec6df8e-1ee4-4531-8b28-63d57d251eda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:to="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c15b87fa-03d7-4f77-8ef5-bff4051cc6bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c15b87fa-03d7-4f77-8ef5-bff4051cc6bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_591de1df-b509-4ded-88f8-efea79785dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_us-gaap_ShareBasedCompensation_591de1df-b509-4ded-88f8-efea79785dd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7b98b4a2-d7d9-489f-9468-aa208104f642" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7b98b4a2-d7d9-489f-9468-aa208104f642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a122bcf8-70e7-41ce-87d1-0724bf3ac754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_a122bcf8-70e7-41ce-87d1-0724bf3ac754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_0a51f168-c25c-48f0-bafb-74b137a5ec59" xlink:href="abus-20220331.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_0a51f168-c25c-48f0-bafb-74b137a5ec59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_b854e4f0-0f6e-4cdf-a918-b7f814d847e7" xlink:href="abus-20220331.xsd#abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_abus_NonCashInterestExpenseRelatedToSaleOfFutureRoyalties_b854e4f0-0f6e-4cdf-a918-b7f814d847e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_aa4a3d73-5205-445c-903f-0b3f76323751" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_921262dd-8678-4e38-a58c-20a662f770db" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_aa4a3d73-5205-445c-903f-0b3f76323751" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f5f2a7c-5e21-498d-b4d6-6d088db2f987" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f5f2a7c-5e21-498d-b4d6-6d088db2f987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c557ef0e-b2a0-4985-8695-07c834db0eb7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c557ef0e-b2a0-4985-8695-07c834db0eb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7ed856cd-98a7-40ab-84f8-1aed622d54af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_7ed856cd-98a7-40ab-84f8-1aed622d54af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5d2eecef-e135-4e52-b34f-d5c54552b221" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_5d2eecef-e135-4e52-b34f-d5c54552b221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_cfbe010f-32ac-41cb-a6fc-38a0a4851a60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_68cfd6f7-d10e-4cf7-8899-02d5b88ba2d4" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_cfbe010f-32ac-41cb-a6fc-38a0a4851a60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90bee6d0-c74c-4728-9732-2cfef389c970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_181e5650-cf05-4c5a-abe7-22a5bd04512b" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_90bee6d0-c74c-4728-9732-2cfef389c970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_fbb9b695-2c60-4a2d-9ad6-ba5638066886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_fbb9b695-2c60-4a2d-9ad6-ba5638066886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a8584bcf-9294-4cc1-b95b-b58f42501c16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:to="loc_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_a8584bcf-9294-4cc1-b95b-b58f42501c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d8c3c487-1cb9-47ca-b382-74cead6881f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d8c3c487-1cb9-47ca-b382-74cead6881f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f89e4daa-24d0-434d-a104-d505849122b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_66c514ea-cb56-4186-97dd-a083188195fe" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_f89e4daa-24d0-434d-a104-d505849122b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9df1dc82-e9a3-499e-a8c5-18033a6e0eb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_9df1dc82-e9a3-499e-a8c5-18033a6e0eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b96c22b8-507d-4aad-b25a-10dda9e148cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b96c22b8-507d-4aad-b25a-10dda9e148cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_7a0ee6ce-6509-40f8-96f1-7c4d2c2502b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:to="loc_us-gaap_ProceedsFromStockPlans_7a0ee6ce-6509-40f8-96f1-7c4d2c2502b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edff77db-8448-4d20-938b-c7dd8aabae42" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_e482151f-b639-49c9-8dfa-4d7fbf76e915" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_edff77db-8448-4d20-938b-c7dd8aabae42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edeec956-1758-45d3-b766-8fcaf27e1aa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edeec956-1758-45d3-b766-8fcaf27e1aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ac041ec-e0e5-4b48-8956-fc58d8aefc8d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8ac041ec-e0e5-4b48-8956-fc58d8aefc8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58846618-2b8d-4fda-9e81-e853330b443e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_58846618-2b8d-4fda-9e81-e853330b443e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e13418bb-c95f-497b-88c0-06573ebdd596" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e13418bb-c95f-497b-88c0-06573ebdd596" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_b534c5e3-e90d-4671-b7b3-f01b6a26fe7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_2fc8c195-fdb6-489c-8fea-67c78c85d94f" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_b534c5e3-e90d-4671-b7b3-f01b6a26fe7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsPreferredStockCash_519183df-91fc-4439-b02a-99453af489d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsPreferredStockCash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_b534c5e3-e90d-4671-b7b3-f01b6a26fe7a" xlink:to="loc_us-gaap_DividendsPreferredStockCash_519183df-91fc-4439-b02a-99453af489d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Natureofbusinessandfutureoperations" xlink:type="simple" xlink:href="abus-20220331.xsd#Natureofbusinessandfutureoperations"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Natureofbusinessandfutureoperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efe2ba55-93f7-439a-b7d3-3502feaf08c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_8f95092c-0be8-440c-950a-4ae851cc7fe3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efe2ba55-93f7-439a-b7d3-3502feaf08c2" xlink:to="loc_us-gaap_NatureOfOperations_8f95092c-0be8-440c-950a-4ae851cc7fe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/NatureofbusinessandfutureoperationsDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#NatureofbusinessandfutureoperationsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/NatureofbusinessandfutureoperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dba56ade-0015-4608-8a04-edec2dc24301" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_5795180f-1da6-4678-a8a7-670ab577a8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsAndShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dba56ade-0015-4608-8a04-edec2dc24301" xlink:to="loc_us-gaap_CashCashEquivalentsAndShortTermInvestments_5795180f-1da6-4678-a8a7-670ab577a8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1abfd774-f598-4971-86be-24760870d8cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dba56ade-0015-4608-8a04-edec2dc24301" xlink:to="loc_us-gaap_LongTermDebt_1abfd774-f598-4971-86be-24760870d8cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Significantaccountingpolicies" xlink:type="simple" xlink:href="abus-20220331.xsd#Significantaccountingpolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Significantaccountingpolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_493e728f-1eab-44a4-a58a-6daf12271a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1ebf0952-217d-450c-bcd3-3ae5b46ead55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_493e728f-1eab-44a4-a58a-6daf12271a67" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_1ebf0952-217d-450c-bcd3-3ae5b46ead55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SignificantaccountingpoliciesPolicies" xlink:type="simple" xlink:href="abus-20220331.xsd#SignificantaccountingpoliciesPolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SignificantaccountingpoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6b21f41d-6a80-4972-bd8f-82f43929a7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_6b21f41d-6a80-4972-bd8f-82f43929a7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_c12892f3-406b-49de-835f-64a0f664f0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_c12892f3-406b-49de-835f-64a0f664f0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_b80b9785-ab5d-4722-9d01-1069ed1629de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_b80b9785-ab5d-4722-9d01-1069ed1629de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4c287eb0-cb1b-4315-a1e0-c01fa99fd7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_4c287eb0-cb1b-4315-a1e0-c01fa99fd7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3486b7c4-2c63-4cf1-80cf-c85d0ce9dd52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_3486b7c4-2c63-4cf1-80cf-c85d0ce9dd52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa6c977d-c239-4357-aa03-25a04999e6c6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_fa6c977d-c239-4357-aa03-25a04999e6c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5d12d13d-2c9c-4317-aa28-3905b2bf94a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d839403b-1847-4bd8-9f35-c4e4410a8308" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_5d12d13d-2c9c-4317-aa28-3905b2bf94a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SignificantaccountingpoliciesDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#SignificantaccountingpoliciesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SignificantaccountingpoliciesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ae39dd54-e5d9-4103-ab4e-d4bc293f954f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_9a49f798-8c63-44b2-ac5f-e8ca73bb814e" xlink:href="abus-20220331.xsd#abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae39dd54-e5d9-4103-ab4e-d4bc293f954f" xlink:to="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_9a49f798-8c63-44b2-ac5f-e8ca73bb814e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_0109c2d8-d69e-44c3-8866-6ddd1315aeda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ae39dd54-e5d9-4103-ab4e-d4bc293f954f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_0109c2d8-d69e-44c3-8866-6ddd1315aeda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_403efc64-7155-437c-908d-3b0fbf26a54e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_0109c2d8-d69e-44c3-8866-6ddd1315aeda" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_403efc64-7155-437c-908d-3b0fbf26a54e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1fb0de17-073c-4670-89d7-dfe43e82b903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_403efc64-7155-437c-908d-3b0fbf26a54e" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1fb0de17-073c-4670-89d7-dfe43e82b903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_679f4c8e-6a6d-41bb-9dc4-5bc7d9b51938" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1fb0de17-073c-4670-89d7-dfe43e82b903" xlink:to="loc_us-gaap_EmployeeStockOptionMember_679f4c8e-6a6d-41bb-9dc4-5bc7d9b51938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_4fccae46-4573-43a2-9636-fe0a04a87970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_0109c2d8-d69e-44c3-8866-6ddd1315aeda" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_4fccae46-4573-43a2-9636-fe0a04a87970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_affe0d89-ecbe-4c10-9662-f4c91cabed64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_4fccae46-4573-43a2-9636-fe0a04a87970" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_affe0d89-ecbe-4c10-9662-f4c91cabed64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_93e696a5-b402-4493-9feb-e2f2cf5b08a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_4fccae46-4573-43a2-9636-fe0a04a87970" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_93e696a5-b402-4493-9feb-e2f2cf5b08a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_f846bc21-8e84-4e0f-ac31-5596832e0cff" xlink:href="abus-20220331.xsd#abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_4fccae46-4573-43a2-9636-fe0a04a87970" xlink:to="loc_abus_WhollyOwnedSubsidiariesIncludedinFinancialStatements_f846bc21-8e84-4e0f-ac31-5596832e0cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Fairvaluemeasurements" xlink:type="simple" xlink:href="abus-20220331.xsd#Fairvaluemeasurements"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Fairvaluemeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bebe8dc9-d5e3-45ac-8419-cb92cf957edc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_46256104-350f-409a-949a-7eee20c9af83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bebe8dc9-d5e3-45ac-8419-cb92cf957edc" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_46256104-350f-409a-949a-7eee20c9af83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsTables" xlink:type="simple" xlink:href="abus-20220331.xsd#FairvaluemeasurementsTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b9e03c6b-175d-4e95-a8c0-f5785557e3e1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_897efc4c-4e42-460e-8942-55daba42ca23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9e03c6b-175d-4e95-a8c0-f5785557e3e1" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_897efc4c-4e42-460e-8942-55daba42ca23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_4a906160-8b5a-4e85-9da3-681ecc890720" xlink:href="abus-20220331.xsd#abus_ChangesInFairValueofLiabilityOptionTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9e03c6b-175d-4e95-a8c0-f5785557e3e1" xlink:to="loc_abus_ChangesInFairValueofLiabilityOptionTableTextBlock_4a906160-8b5a-4e85-9da3-681ecc890720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_2a0518dd-9775-4696-b8df-8f887cd54da2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b9e03c6b-175d-4e95-a8c0-f5785557e3e1" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionContingentConsiderationTextBlock_2a0518dd-9775-4696-b8df-8f887cd54da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#FairvaluemeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bf0dcb1f-188e-4586-a267-bac4a102fab0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d8459afb-cc3e-4a39-9e39-a527e524735b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bf0dcb1f-188e-4586-a267-bac4a102fab0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_d8459afb-cc3e-4a39-9e39-a527e524735b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_901a0ef4-4226-45c4-ba30-03f40ee2c0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bf0dcb1f-188e-4586-a267-bac4a102fab0" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_901a0ef4-4226-45c4-ba30-03f40ee2c0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsAssetsandLiabilitiesMeasuredatFairValueonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_186b1347-3f2e-484c-9743-2dfef61a874e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e528b47c-2ac8-4c68-a6ea-84c768ead195" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_186b1347-3f2e-484c-9743-2dfef61a874e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e528b47c-2ac8-4c68-a6ea-84c768ead195" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_50afc22d-6447-4658-ace9-a281660f128c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e528b47c-2ac8-4c68-a6ea-84c768ead195" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_50afc22d-6447-4658-ace9-a281660f128c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e783814-c35b-4dbe-ab89-69b18f23925a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_50afc22d-6447-4658-ace9-a281660f128c" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e783814-c35b-4dbe-ab89-69b18f23925a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_5cf8a0b3-0307-49d9-9b55-37aa9a149ca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_6e783814-c35b-4dbe-ab89-69b18f23925a" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_5cf8a0b3-0307-49d9-9b55-37aa9a149ca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b782307b-b19b-4afc-8b63-982aaac712b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e528b47c-2ac8-4c68-a6ea-84c768ead195" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b782307b-b19b-4afc-8b63-982aaac712b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b766c47-2e3b-4b2b-9ea9-b7b56544856a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_b782307b-b19b-4afc-8b63-982aaac712b7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b766c47-2e3b-4b2b-9ea9-b7b56544856a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_90a3e143-c4d6-481d-9224-1cb4d362af0e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b766c47-2e3b-4b2b-9ea9-b7b56544856a" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_90a3e143-c4d6-481d-9224-1cb4d362af0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_17b300c6-b4fe-487c-a75d-fc791739d582" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b766c47-2e3b-4b2b-9ea9-b7b56544856a" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_17b300c6-b4fe-487c-a75d-fc791739d582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_2c859a81-ec6e-4601-9de5-60b35ff90dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2b766c47-2e3b-4b2b-9ea9-b7b56544856a" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_2c859a81-ec6e-4601-9de5-60b35ff90dfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a1a9014d-1f5e-46fe-b6ac-9035d0e524fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e528b47c-2ac8-4c68-a6ea-84c768ead195" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a1a9014d-1f5e-46fe-b6ac-9035d0e524fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a1a9014d-1f5e-46fe-b6ac-9035d0e524fc" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_54dbde46-5be5-4444-b669-7b5cfe85c622" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_54dbde46-5be5-4444-b669-7b5cfe85c622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_b23354da-e38e-4e1d-b44b-91e1ceecfbb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_b23354da-e38e-4e1d-b44b-91e1ceecfbb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2b4c21aa-5e5d-44dc-aed9-df0ae3218b3b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:to="loc_us-gaap_LongTermInvestments_2b4c21aa-5e5d-44dc-aed9-df0ae3218b3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_0faed7f7-7608-436f-8ed3-21e39ed753a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_97495394-8c90-4112-88f4-47418f1ef598" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_0faed7f7-7608-436f-8ed3-21e39ed753a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e51e0111-d8e7-4e84-bf61-5f1880e2745f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_a1a9014d-1f5e-46fe-b6ac-9035d0e524fc" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e51e0111-d8e7-4e84-bf61-5f1880e2745f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_fe7887ab-4bd2-41e0-86f3-2ac0e6f0561a" xlink:href="abus-20220331.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e51e0111-d8e7-4e84-bf61-5f1880e2745f" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_fe7887ab-4bd2-41e0-86f3-2ac0e6f0561a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6ed2cba3-f85a-4d1a-8d4b-aa66ccb34988" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e51e0111-d8e7-4e84-bf61-5f1880e2745f" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_6ed2cba3-f85a-4d1a-8d4b-aa66ccb34988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ec56da96-6e81-4a32-b324-4caec91dcea0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_e51e0111-d8e7-4e84-bf61-5f1880e2745f" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ec56da96-6e81-4a32-b324-4caec91dcea0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofLiabilitiesClassifiedasStockOptionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4cee3556-357b-4318-a9c7-301aca462114" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_400f7047-3a3b-4aa4-a3e1-4fb4a4eaac31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4cee3556-357b-4318-a9c7-301aca462114" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_400f7047-3a3b-4aa4-a3e1-4fb4a4eaac31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f5ae66ed-a765-4fc0-906c-ed195f867aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_400f7047-3a3b-4aa4-a3e1-4fb4a4eaac31" xlink:to="loc_us-gaap_AwardTypeAxis_f5ae66ed-a765-4fc0-906c-ed195f867aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_033a9875-b410-4b2a-9b0f-daf7c2dea689" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f5ae66ed-a765-4fc0-906c-ed195f867aac" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_033a9875-b410-4b2a-9b0f-daf7c2dea689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_1e777527-8e37-4b7a-b13a-5588d4c0e96c" xlink:href="abus-20220331.xsd#abus_EmployeeStockOptionLiabilityClassifiedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_033a9875-b410-4b2a-9b0f-daf7c2dea689" xlink:to="loc_abus_EmployeeStockOptionLiabilityClassifiedMember_1e777527-8e37-4b7a-b13a-5588d4c0e96c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_772c0c6e-0bb8-4d57-ae17-7f62cf5289b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_400f7047-3a3b-4aa4-a3e1-4fb4a4eaac31" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_772c0c6e-0bb8-4d57-ae17-7f62cf5289b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:href="abus-20220331.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_772c0c6e-0bb8-4d57-ae17-7f62cf5289b0" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f9e0fd14-e034-4ab6-b775-2c4dcd30c5d4" xlink:href="abus-20220331.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f9e0fd14-e034-4ab6-b775-2c4dcd30c5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_de389d49-4c58-4486-83dd-f7191429f9c1" xlink:href="abus-20220331.xsd#abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:to="loc_abus_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodFairValue_de389d49-4c58-4486-83dd-f7191429f9c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_b5bf72ad-4ca4-45a6-b33d-f6f87ec5380f" xlink:href="abus-20220331.xsd#abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:to="loc_abus_IncreaseDecreaseinFairValueofLiabilityClassifiedOptions_b5bf72ad-4ca4-45a6-b33d-f6f87ec5380f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f1b3b113-e4e3-4362-8336-13daed90857d" xlink:href="abus-20220331.xsd#abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_d736b445-a4c2-4a38-9ab0-bf6404345027" xlink:to="loc_abus_EmployeeStockOptionsLiabilityClassifiedOutstandingFairValueDisclosure_f1b3b113-e4e3-4362-8336-13daed90857d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairvaluemeasurementsChangesinFairValueofContingentConsiderationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_184ee827-f997-4de5-ab40-c6e5a0808e47" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_0e0724be-ec4d-4a8b-9e9a-e755c76667c5" xlink:href="abus-20220331.xsd#abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_184ee827-f997-4de5-ab40-c6e5a0808e47" xlink:to="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_0e0724be-ec4d-4a8b-9e9a-e755c76667c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_71053b1c-f2af-4825-ae5d-b095ac4c25be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_0e0724be-ec4d-4a8b-9e9a-e755c76667c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_71053b1c-f2af-4825-ae5d-b095ac4c25be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1ecedf03-5059-479e-8d1d-d146b55bf127" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_0e0724be-ec4d-4a8b-9e9a-e755c76667c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1ecedf03-5059-479e-8d1d-d146b55bf127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_626075e8-fed9-47c6-b5fa-51095722a94e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_FairValueLiabilitiesMeasuredonRecurringBasisRollForward_0e0724be-ec4d-4a8b-9e9a-e755c76667c5" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_626075e8-fed9-47c6-b5fa-51095722a94e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="simple" xlink:href="abus-20220331.xsd#FairValueMeasuresandDisclosuresPolicies"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/FairValueMeasuresandDisclosuresPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_2730aa20-01e5-4dd7-ad81-6f2da13e5389" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3f9ad38e-df13-47a4-9e03-64f8910c1983" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_2730aa20-01e5-4dd7-ad81-6f2da13e5389" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3f9ad38e-df13-47a4-9e03-64f8910c1983" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Investmentsinmarketablesecurities" xlink:type="simple" xlink:href="abus-20220331.xsd#Investmentsinmarketablesecurities"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Investmentsinmarketablesecurities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e14abd58-836d-4db7-99df-3d7671aa0485" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_31e6550e-abe7-47bf-b2f4-d358233aad6c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_e14abd58-836d-4db7-99df-3d7671aa0485" xlink:to="loc_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_31e6550e-abe7-47bf-b2f4-d358233aad6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="simple" xlink:href="abus-20220331.xsd#InvestmentsinmarketablesecuritiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5b6c8346-5d92-496a-87d5-10d448ce91af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTextBlock_243ef82f-1981-4542-a9e4-6330649dc825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_5b6c8346-5d92-496a-87d5-10d448ce91af" xlink:to="loc_us-gaap_MarketableSecuritiesTextBlock_243ef82f-1981-4542-a9e4-6330649dc825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_534b865c-723f-4054-8da3-8ac24ce6507a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MarketableSecuritiesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_534b865c-723f-4054-8da3-8ac24ce6507a" xlink:to="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_893b1758-8a98-4fac-b118-a331f8fd5d62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_893b1758-8a98-4fac-b118-a331f8fd5d62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_14930bdf-8813-4b1e-b32b-bd215a488ac0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_893b1758-8a98-4fac-b118-a331f8fd5d62" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_14930bdf-8813-4b1e-b32b-bd215a488ac0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsMember_4a12b564-29a9-4e77-8466-64a63b9a9361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_14930bdf-8813-4b1e-b32b-bd215a488ac0" xlink:to="loc_us-gaap_CashEquivalentsMember_4a12b564-29a9-4e77-8466-64a63b9a9361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_6d03788f-3f04-4148-a751-8cdb08434e32" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:to="loc_us-gaap_FinancialInstrumentAxis_6d03788f-3f04-4148-a751-8cdb08434e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_6d03788f-3f04-4148-a751-8cdb08434e32" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentMoneyMarkeTFundMember_55f672b2-5781-425c-a14b-01817502d141" xlink:href="abus-20220331.xsd#abus_USGovernmentMoneyMarkeTFundMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:to="loc_abus_USGovernmentMoneyMarkeTFundMember_55f672b2-5781-425c-a14b-01817502d141" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USTreasuryBillSecuritiesMember_a83c7b5d-dc34-468a-bd88-8ac92a630f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasuryBillSecuritiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:to="loc_us-gaap_USTreasuryBillSecuritiesMember_a83c7b5d-dc34-468a-bd88-8ac92a630f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentAgencyBondsMember_bb468e46-ceab-47e9-b6d5-789c224a1988" xlink:href="abus-20220331.xsd#abus_USGovernmentAgencyBondsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:to="loc_abus_USGovernmentAgencyBondsMember_bb468e46-ceab-47e9-b6d5-789c224a1988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_USGovernmentBondsMember_10ab301b-cc96-4e54-a73d-79c66126ef42" xlink:href="abus-20220331.xsd#abus_USGovernmentBondsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_85e47e86-b33b-4a0e-aac5-e7cadb118cf2" xlink:to="loc_abus_USGovernmentBondsMember_10ab301b-cc96-4e54-a73d-79c66126ef42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_0977ce12-0d5b-4bfd-8020-d2adf7601807" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:to="loc_us-gaap_InvestmentTypeAxis_0977ce12-0d5b-4bfd-8020-d2adf7601807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_4fc5271b-5531-4e68-aae3-792c6e91ca41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_0977ce12-0d5b-4bfd-8020-d2adf7601807" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_4fc5271b-5531-4e68-aae3-792c6e91ca41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestmentsMember_4b978410-13db-4a13-9604-b6727b4ba3c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4fc5271b-5531-4e68-aae3-792c6e91ca41" xlink:to="loc_us-gaap_ShortTermInvestmentsMember_4b978410-13db-4a13-9604-b6727b4ba3c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LongTermInvestmentsMember_f1e4aaf3-90eb-4911-b487-cbb081ec386c" xlink:href="abus-20220331.xsd#abus_LongTermInvestmentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_4fc5271b-5531-4e68-aae3-792c6e91ca41" xlink:to="loc_abus_LongTermInvestmentsMember_f1e4aaf3-90eb-4911-b487-cbb081ec386c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MarketableSecuritiesTable_d5953034-7200-41b1-831a-70e1be133070" xlink:to="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_db2c90f0-7c85-4a23-948d-2128b482db95" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_db2c90f0-7c85-4a23-948d-2128b482db95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_41b7ddb1-7a8c-401b-922d-a538484e63f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_41b7ddb1-7a8c-401b-922d-a538484e63f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_178449ce-8f45-45d6-9769-617dd753ef74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_178449ce-8f45-45d6-9769-617dd753ef74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99f8be1d-ac21-405a-b9d0-12c1aa47df69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_99f8be1d-ac21-405a-b9d0-12c1aa47df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2817f200-6479-4041-be9d-8d77144ad739" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_2817f200-6479-4041-be9d-8d77144ad739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f2451819-40a3-4347-be24-3f447e84fdd4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_8cb2d03d-4da2-40a8-87f2-767e9a9a6d25" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f2451819-40a3-4347-be24-3f447e84fdd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesNarrativeDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#InvestmentsinmarketablesecuritiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentsinmarketablesecuritiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_166e94e7-b3d1-40c1-927c-a83ea74003b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6656800c-5054-4c54-a450-236f2a7b7cb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_166e94e7-b3d1-40c1-927c-a83ea74003b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_6656800c-5054-4c54-a450-236f2a7b7cb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e1402653-ecc9-4c99-a654-cccc9bf9fd56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_166e94e7-b3d1-40c1-927c-a83ea74003b2" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_e1402653-ecc9-4c99-a654-cccc9bf9fd56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesRealizedGainLoss_a8635805-133f-4f5f-b482-1ff9b29029cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesRealizedGainLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_166e94e7-b3d1-40c1-927c-a83ea74003b2" xlink:to="loc_us-gaap_DebtSecuritiesRealizedGainLoss_a8635805-133f-4f5f-b482-1ff9b29029cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentinGenevant" xlink:type="simple" xlink:href="abus-20220331.xsd#InvestmentinGenevant"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentinGenevant" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_be45d262-89e8-46db-b29e-33dd621d4c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_6df34d4d-6bdc-4d8d-a911-511b0b73bf03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_be45d262-89e8-46db-b29e-33dd621d4c68" xlink:to="loc_us-gaap_EquityMethodInvestmentsDisclosureTextBlock_6df34d4d-6bdc-4d8d-a911-511b0b73bf03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/InvestmentinGenevantDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#InvestmentinGenevantDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/InvestmentinGenevantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c7979a41-fb2d-429d-b1c8-84262100337c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e3b0c9ef-c2b0-40d6-a31e-84aebb807c44" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract_c7979a41-fb2d-429d-b1c8-84262100337c" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e3b0c9ef-c2b0-40d6-a31e-84aebb807c44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_725afed9-5c2c-4d65-8a57-77ad576fb155" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e3b0c9ef-c2b0-40d6-a31e-84aebb807c44" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_725afed9-5c2c-4d65-8a57-77ad576fb155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_c4088129-af8d-40d5-9b61-9a041f2471b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_725afed9-5c2c-4d65-8a57-77ad576fb155" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_c4088129-af8d-40d5-9b61-9a041f2471b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_ab4048e2-4d8b-4a04-95ae-9d304ec2fdea" xlink:href="abus-20220331.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_c4088129-af8d-40d5-9b61-9a041f2471b7" xlink:to="loc_abus_GenevantSciencesCorporationMember_ab4048e2-4d8b-4a04-95ae-9d304ec2fdea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEquityMethodInvestmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsTable_e3b0c9ef-c2b0-40d6-a31e-84aebb807c44" xlink:to="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SubLicensingRevenuePercentage_c9b08b1b-607b-4be1-bbfa-c95c7d9a487b" xlink:href="abus-20220331.xsd#abus_SubLicensingRevenuePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:to="loc_abus_SubLicensingRevenuePercentage_c9b08b1b-607b-4be1-bbfa-c95c7d9a487b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_34b299db-06b7-4bf6-9714-562717e295ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestmentOwnershipPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:to="loc_us-gaap_EquityMethodInvestmentOwnershipPercentage_34b299db-06b7-4bf6-9714-562717e295ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestments_0abf2eee-0ece-4fa7-ab44-87a8cbbfa11c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityMethodInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:to="loc_us-gaap_EquityMethodInvestments_0abf2eee-0ece-4fa7-ab44-87a8cbbfa11c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_BonaFideCollaborationPercentage_69f60f82-5708-4176-af9e-fd4362b1ac45" xlink:href="abus-20220331.xsd#abus_BonaFideCollaborationPercentage"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEquityMethodInvestmentsLineItems_83bfd472-c451-404e-9475-39b56503dbd9" xlink:to="loc_abus_BonaFideCollaborationPercentage_69f60f82-5708-4176-af9e-fd4362b1ac45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Accountspayableandaccruedliabilities" xlink:type="simple" xlink:href="abus-20220331.xsd#Accountspayableandaccruedliabilities"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Accountspayableandaccruedliabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_d488dd3d-41f9-46e1-8bf6-4f82cc2566ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f3dd4375-aec8-4ba4-a402-a2a34e04f5bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_d488dd3d-41f9-46e1-8bf6-4f82cc2566ad" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_f3dd4375-aec8-4ba4-a402-a2a34e04f5bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="simple" xlink:href="abus-20220331.xsd#AccountspayableandaccruedliabilitiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_45d71fe7-a652-41b0-9ece-ebbb23b01f31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_58e0d129-3144-4d4a-9cc4-822e23dcf74d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_45d71fe7-a652-41b0-9ece-ebbb23b01f31" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_58e0d129-3144-4d4a-9cc4-822e23dcf74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#AccountspayableandaccruedliabilitiesDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/AccountspayableandaccruedliabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_c5d1bdcb-ced6-41a1-892d-91f66697e754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_c5d1bdcb-ced6-41a1-892d-91f66697e754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedResearchAndDevelopment_35b30301-ab92-4e89-a90f-7e0efecfa25e" xlink:href="abus-20220331.xsd#abus_AccruedResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_abus_AccruedResearchAndDevelopment_35b30301-ab92-4e89-a90f-7e0efecfa25e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_4992a2a5-5de2-43cf-a153-d5af3ddf01d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_4992a2a5-5de2-43cf-a153-d5af3ddf01d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AccruedPayrollCurrent_d9d9c600-0fc5-4ad6-8a2d-dc103440604c" xlink:href="abus-20220331.xsd#abus_AccruedPayrollCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_abus_AccruedPayrollCurrent_d9d9c600-0fc5-4ad6-8a2d-dc103440604c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cc7dd801-860d-4d33-9006-0058fd8afd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_cc7dd801-860d-4d33-9006-0058fd8afd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_835a25cb-a0be-444e-8401-f27e13f9e5e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_fcaff3e1-8f5d-4fb3-bdb8-37c9d21f15ae" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent_835a25cb-a0be-444e-8401-f27e13f9e5e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Saleoffutureroyalties" xlink:type="simple" xlink:href="abus-20220331.xsd#Saleoffutureroyalties"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Saleoffutureroyalties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8a0b72d3-8f38-4ece-983a-6b4ca143a70c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_b38ac764-0404-4bbe-bce2-4a1070c289a2" xlink:href="abus-20220331.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_8a0b72d3-8f38-4ece-983a-6b4ca143a70c" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesTextBlock_b38ac764-0404-4bbe-bce2-4a1070c289a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesTables" xlink:type="simple" xlink:href="abus-20220331.xsd#SaleoffutureroyaltiesTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5ba81948-1017-414f-9a02-84a75abe61a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_d43f4a01-2027-45f0-a5c9-0a0802d224a1" xlink:href="abus-20220331.xsd#abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_5ba81948-1017-414f-9a02-84a75abe61a9" xlink:to="loc_abus_LiabilitiesRelatedToSaleOfFutureRoyaltiesRollForwardTableTextBlock_d43f4a01-2027-45f0-a5c9-0a0802d224a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#SaleoffutureroyaltiesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_7ecb20bf-a6b1-43f6-8295-aeb949fced0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AirlineProductsAndServicesTable_c70c32b4-ccb2-4860-9144-1a8c1a44798b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AirlineProductsAndServicesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_7ecb20bf-a6b1-43f6-8295-aeb949fced0b" xlink:to="loc_us-gaap_AirlineProductsAndServicesTable_c70c32b4-ccb2-4860-9144-1a8c1a44798b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2ed6e674-00d9-490f-a37d-ef80b5132bdb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_c70c32b4-ccb2-4860-9144-1a8c1a44798b" xlink:to="loc_srt_CounterpartyNameAxis_2ed6e674-00d9-490f-a37d-ef80b5132bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29f2c4-44d8-41d2-a966-88006202e63f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2ed6e674-00d9-490f-a37d-ef80b5132bdb" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29f2c4-44d8-41d2-a966-88006202e63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_fd40d50d-37e7-4042-897d-02f2212154b3" xlink:href="abus-20220331.xsd#abus_OMERSMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_6b29f2c4-44d8-41d2-a966-88006202e63f" xlink:to="loc_abus_OMERSMember_fd40d50d-37e7-4042-897d-02f2212154b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_31b300aa-9196-43ad-b9ce-b3557fe68ca9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_c70c32b4-ccb2-4860-9144-1a8c1a44798b" xlink:to="loc_srt_RangeAxis_31b300aa-9196-43ad-b9ce-b3557fe68ca9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_44b8887e-b478-43df-8acc-6245167b1b72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_31b300aa-9196-43ad-b9ce-b3557fe68ca9" xlink:to="loc_srt_RangeMember_44b8887e-b478-43df-8acc-6245167b1b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_737595c6-0381-457a-bc56-53b70fb477e9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44b8887e-b478-43df-8acc-6245167b1b72" xlink:to="loc_srt_MinimumMember_737595c6-0381-457a-bc56-53b70fb477e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a68084db-4fa3-4849-8502-1cdaac8a5ca3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_44b8887e-b478-43df-8acc-6245167b1b72" xlink:to="loc_srt_MaximumMember_a68084db-4fa3-4849-8502-1cdaac8a5ca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:href="abus-20220331.xsd#abus_OtherLiabilitiesDisclosureLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AirlineProductsAndServicesTable_c70c32b4-ccb2-4860-9144-1a8c1a44798b" xlink:to="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPercentageofInterestSold_2ebdb7d1-0bea-45dd-8983-b757540775b2" xlink:href="abus-20220331.xsd#abus_RoyaltyPercentageofInterestSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_RoyaltyPercentageofInterestSold_2ebdb7d1-0bea-45dd-8983-b757540775b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_8c866b8e-0032-4bde-821d-458463e2a35a" xlink:href="abus-20220331.xsd#abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_8c866b8e-0032-4bde-821d-458463e2a35a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_760c63f9-e109-4034-b03a-52468dae4d1b" xlink:href="abus-20220331.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_760c63f9-e109-4034-b03a-52468dae4d1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_f32c39c8-106f-4fc8-8b5e-ca850c5e50d1" xlink:href="abus-20220331.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_f32c39c8-106f-4fc8-8b5e-ca850c5e50d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_4a94f366-12ab-4bbd-a8e7-bbec5c2509ab" xlink:href="abus-20220331.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_4a94f366-12ab-4bbd-a8e7-bbec5c2509ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_fccc2dca-513f-4037-93ba-f881ccd2a06d" xlink:href="abus-20220331.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_RoyaltyPayable_fccc2dca-513f-4037-93ba-f881ccd2a06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_013ebb3e-478a-4516-9f56-571830627891" xlink:href="abus-20220331.xsd#abus_TransactionCostsRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_TransactionCostsRelatedToSaleOfFutureRoyalties_013ebb3e-478a-4516-9f56-571830627891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_3a24f760-4fa8-4d03-a094-90f098291efb" xlink:href="abus-20220331.xsd#abus_EffectiveAnnualInterestRateOfRoyaltyLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_EffectiveAnnualInterestRateOfRoyaltyLiability_3a24f760-4fa8-4d03-a094-90f098291efb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_c5c4b46c-9b34-45bb-8ff5-b36b820da8bb" xlink:href="abus-20220331.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_c5c4b46c-9b34-45bb-8ff5-b36b820da8bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_eb4048fa-19bc-474c-8643-7051a8fd63cb" xlink:href="abus-20220331.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_OtherLiabilitiesDisclosureLineItems_04d847f2-f25d-4ffe-8503-fa4ae36a657a" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_eb4048fa-19bc-474c-8643-7051a8fd63cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/SaleoffutureroyaltiesLiabilityActivityDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#SaleoffutureroyaltiesLiabilityActivityDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/SaleoffutureroyaltiesLiabilityActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_7b47a1da-0421-402c-b33b-046e3e69dcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:href="abus-20220331.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureAbstract_7b47a1da-0421-402c-b33b-046e3e69dcf3" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_1e238423-3330-466a-8105-f89224f76dc7" xlink:href="abus-20220331.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_1e238423-3330-466a-8105-f89224f76dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_2da2bfd8-d5ae-4ebe-8c74-4ef3d2c51d0b" xlink:href="abus-20220331.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashRoyaltyIncome_2da2bfd8-d5ae-4ebe-8c74-4ef3d2c51d0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_3c4803e4-d245-4b4c-8a01-194c33117602" xlink:href="abus-20220331.xsd#abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:to="loc_abus_LiabilityFromSaleOfFutureRoyaltiesNonCashExpense_3c4803e4-d245-4b4c-8a01-194c33117602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_f3179a65-5ca7-480a-89f5-0cd9d0e950b9" xlink:href="abus-20220331.xsd#abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesRollForward_06d59edd-4796-4ec2-8b31-1c099f66f6af" xlink:to="loc_abus_LiabilityRelatedToSaleOfFutureRoyaltiesNoncurrent_f3179a65-5ca7-480a-89f5-0cd9d0e950b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Contingenciesandcommitments" xlink:type="simple" xlink:href="abus-20220331.xsd#Contingenciesandcommitments"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Contingenciesandcommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_757312c2-4109-4c54-b62e-53f67dc0d06a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5fb7c0d0-19a7-49e1-92b8-a530edb265ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_757312c2-4109-4c54-b62e-53f67dc0d06a" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_5fb7c0d0-19a7-49e1-92b8-a530edb265ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ContingenciesandcommitmentsDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#ContingenciesandcommitmentsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ContingenciesandcommitmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d6806d71-a187-496e-8094-0026f0c94613" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:href="abus-20220331.xsd#abus_ContingenciesandCommitmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d6806d71-a187-496e-8094-0026f0c94613" xlink:to="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_cbf463bb-be52-4122-b84c-9377be86cd3a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_srt_LitigationCaseAxis_cbf463bb-be52-4122-b84c-9377be86cd3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_594b07e4-1bda-40af-94a9-1d5b0d956b12" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_cbf463bb-be52-4122-b84c-9377be86cd3a" xlink:to="loc_srt_LitigationCaseTypeDomain_594b07e4-1bda-40af-94a9-1d5b0d956b12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_19338eff-dc1c-4f1e-9d48-5b4762ab961e" xlink:href="abus-20220331.xsd#abus_ArbitrationWithTheUniversityOfBritishColumbiaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_594b07e4-1bda-40af-94a9-1d5b0d956b12" xlink:to="loc_abus_ArbitrationWithTheUniversityOfBritishColumbiaMember_19338eff-dc1c-4f1e-9d48-5b4762ab961e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_6910a107-810a-414e-b7a3-136327c8462c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_srt_CounterpartyNameAxis_6910a107-810a-414e-b7a3-136327c8462c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5dd92aad-1141-410c-bd6d-03c16bd8336b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_6910a107-810a-414e-b7a3-136327c8462c" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5dd92aad-1141-410c-bd6d-03c16bd8336b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EnantigensSellingShareholdersMember_6836723c-d172-4169-88d2-83746883f3f7" xlink:href="abus-20220331.xsd#abus_EnantigensSellingShareholdersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_5dd92aad-1141-410c-bd6d-03c16bd8336b" xlink:to="loc_abus_EnantigensSellingShareholdersMember_6836723c-d172-4169-88d2-83746883f3f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_035720fc-d4cb-4ec6-933b-66efc6430c7a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_dei_LegalEntityAxis_035720fc-d4cb-4ec6-933b-66efc6430c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_2a1735d7-dd32-4977-887f-a56b2e04feb7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_035720fc-d4cb-4ec6-933b-66efc6430c7a" xlink:to="loc_dei_EntityDomain_2a1735d7-dd32-4977-887f-a56b2e04feb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusInc.Member_30fd52af-59ab-41f6-873e-e15b087fa55c" xlink:href="abus-20220331.xsd#abus_ArbutusInc.Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_2a1735d7-dd32-4977-887f-a56b2e04feb7" xlink:to="loc_abus_ArbutusInc.Member_30fd52af-59ab-41f6-873e-e15b087fa55c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_e44e98e4-373d-4e21-aedc-112792914567" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_e44e98e4-373d-4e21-aedc-112792914567" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03cc5222-7b9f-4952-82d3-d193beb46fbf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_e44e98e4-373d-4e21-aedc-112792914567" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03cc5222-7b9f-4952-82d3-d193beb46fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_EnantigensSellingShareholdersMember_c24169ca-6be1-436d-8f56-f342b6816dc1" xlink:href="abus-20220331.xsd#abus_EnantigensSellingShareholdersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_03cc5222-7b9f-4952-82d3-d193beb46fbf" xlink:to="loc_abus_EnantigensSellingShareholdersMember_c24169ca-6be1-436d-8f56-f342b6816dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3e2887-c67d-4068-912e-692e83218753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3e2887-c67d-4068-912e-692e83218753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_e49ae421-0aef-4ff9-b73b-17cf49ea4877" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_3b3e2887-c67d-4068-912e-692e83218753" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_e49ae421-0aef-4ff9-b73b-17cf49ea4877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_1c9a35a9-a2c2-4d71-9ed7-d2ee2fb510a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_e49ae421-0aef-4ff9-b73b-17cf49ea4877" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_1c9a35a9-a2c2-4d71-9ed7-d2ee2fb510a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:href="abus-20220331.xsd#abus_ContingenciesandCommitmentsLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsTable_2e8c373b-2142-461c-8909-373ba78791db" xlink:to="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyDamagesSoughtValue_7daadfe0-338f-427f-9610-702aaf6a0c13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LossContingencyDamagesSoughtValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:to="loc_us-gaap_LossContingencyDamagesSoughtValue_7daadfe0-338f-427f-9610-702aaf6a0c13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_64089645-8908-474a-b2d2-c0a5eac30040" xlink:href="abus-20220331.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerLicense_64089645-8908-474a-b2d2-c0a5eac30040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_6e3ea80b-80d7-4575-841c-caa52023b41e" xlink:href="abus-20220331.xsd#abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:to="loc_abus_LicenseAgreementMaximumDevelopmentAndRegulatoryMilestonePaymentsPerRoyalty_6e3ea80b-80d7-4575-841c-caa52023b41e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c44a7a69-fa75-4c9d-ab30-15283e5dd503" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_ContingenciesandCommitmentsLineItems_03656fca-1906-4dc9-8fa4-2183e87991df" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent_c44a7a69-fa75-4c9d-ab30-15283e5dd503" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Collaborationscontractsandlicensingagreements" xlink:type="simple" xlink:href="abus-20220331.xsd#Collaborationscontractsandlicensingagreements"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Collaborationscontractsandlicensingagreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_463459fa-9185-47cc-9541-3af8a528095d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_f8312dad-066b-47ee-bbf3-a9557ab88ce2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_463459fa-9185-47cc-9541-3af8a528095d" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_f8312dad-066b-47ee-bbf3-a9557ab88ce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="simple" xlink:href="abus-20220331.xsd#CollaborationscontractsandlicensingagreementsTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e2037d9d-fdd8-4a25-bd4f-2e54a3293291" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2edc0405-4a2e-45e2-92f5-27daf13f4a16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e2037d9d-fdd8-4a25-bd4f-2e54a3293291" xlink:to="loc_us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock_2edc0405-4a2e-45e2-92f5-27daf13f4a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_dba2895c-a552-496f-8c97-77eca7f570c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e2037d9d-fdd8-4a25-bd4f-2e54a3293291" xlink:to="loc_us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTableTextBlock_dba2895c-a552-496f-8c97-77eca7f570c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#CollaborationscontractsandlicensingagreementsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/CollaborationscontractsandlicensingagreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b4e9bc07-e4cf-46af-a898-e409dd0672e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b4e9bc07-e4cf-46af-a898-e409dd0672e5" xlink:to="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_49a1c505-58b7-490c-88c5-849bb83d93c9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_CounterpartyNameAxis_49a1c505-58b7-490c-88c5-849bb83d93c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_49a1c505-58b7-490c-88c5-849bb83d93c9" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AssemblyBiosciencesIncMember_b7d8d675-4ec3-4af8-80d8-31b383783e95" xlink:href="abus-20220331.xsd#abus_AssemblyBiosciencesIncMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_AssemblyBiosciencesIncMember_b7d8d675-4ec3-4af8-80d8-31b383783e95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OMERSMember_f45e9a60-463d-458d-88a6-1af6d52613e4" xlink:href="abus-20220331.xsd#abus_OMERSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_OMERSMember_f45e9a60-463d-458d-88a6-1af6d52613e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AcuitasTherapeuticsInc.Member_8ecce3e2-2a48-4238-adda-99fa42ee899e" xlink:href="abus-20220331.xsd#abus_AcuitasTherapeuticsInc.Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_AcuitasTherapeuticsInc.Member_8ecce3e2-2a48-4238-adda-99fa42ee899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_c6368a94-9009-460a-96ad-8a08c7c41b32" xlink:href="abus-20220331.xsd#abus_OtherMilestoneandRoyaltyPaymentsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_OtherMilestoneandRoyaltyPaymentsMember_c6368a94-9009-460a-96ad-8a08c7c41b32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_AlnylamPharmaceuticalsIncMember_eba51143-d76c-410f-8058-20fe4d85fb3b" xlink:href="abus-20220331.xsd#abus_AlnylamPharmaceuticalsIncMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_AlnylamPharmaceuticalsIncMember_eba51143-d76c-410f-8058-20fe4d85fb3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_3e230b62-57c1-4230-a03a-0840433b8be6" xlink:href="abus-20220331.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_3e230b62-57c1-4230-a03a-0840433b8be6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_XChemIncAndProterosMember_9ab749cb-e42f-4be6-a888-e3bca7c7d17e" xlink:href="abus-20220331.xsd#abus_XChemIncAndProterosMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_2af42da3-3707-47a0-b4ce-1bb895db0bf3" xlink:to="loc_abus_XChemIncAndProterosMember_9ab749cb-e42f-4be6-a888-e3bca7c7d17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_624d50b2-70e4-4dd1-a396-212559270fcb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_RangeAxis_624d50b2-70e4-4dd1-a396-212559270fcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_fc1d0e4c-5609-4440-98b2-8d5d1de130a7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_624d50b2-70e4-4dd1-a396-212559270fcb" xlink:to="loc_srt_RangeMember_fc1d0e4c-5609-4440-98b2-8d5d1de130a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_3630762b-3fb2-409b-909c-075430e6135f" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc1d0e4c-5609-4440-98b2-8d5d1de130a7" xlink:to="loc_srt_MinimumMember_3630762b-3fb2-409b-909c-075430e6135f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b8c665c3-cc40-4f13-bead-4f0b405024ce" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_fc1d0e4c-5609-4440-98b2-8d5d1de130a7" xlink:to="loc_srt_MaximumMember_b8c665c3-cc40-4f13-bead-4f0b405024ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_241f8b0a-8918-4e50-a1b7-70ad972e2709" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_ProductOrServiceAxis_241f8b0a-8918-4e50-a1b7-70ad972e2709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_8d0c152a-4c34-48fe-802a-cdc1c05713cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_241f8b0a-8918-4e50-a1b7-70ad972e2709" xlink:to="loc_srt_ProductsAndServicesDomain_8d0c152a-4c34-48fe-802a-cdc1c05713cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicenseMember_eb537dcc-7cab-4bdb-91db-cc780c2b4c1f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8d0c152a-4c34-48fe-802a-cdc1c05713cf" xlink:to="loc_us-gaap_LicenseMember_eb537dcc-7cab-4bdb-91db-cc780c2b4c1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyMember_ca654fd1-e9c8-4911-8aef-e6255dd19068" xlink:href="abus-20220331.xsd#abus_NonCashRoyaltyMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_8d0c152a-4c34-48fe-802a-cdc1c05713cf" xlink:to="loc_abus_NonCashRoyaltyMember_ca654fd1-e9c8-4911-8aef-e6255dd19068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_63afb5ce-478a-4724-997a-6d5bc4fd77bb" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_63afb5ce-478a-4724-997a-6d5bc4fd77bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_1f7be7af-9adb-4d3b-aa17-39d795562e72" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_EquityMethodInvesteeNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_63afb5ce-478a-4724-997a-6d5bc4fd77bb" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_1f7be7af-9adb-4d3b-aa17-39d795562e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_6b71d5ba-5644-4310-a8d9-fb4dbda8d50b" xlink:href="abus-20220331.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_EquityMethodInvesteeNameDomain_1f7be7af-9adb-4d3b-aa17-39d795562e72" xlink:to="loc_abus_GenevantSciencesCorporationMember_6b71d5ba-5644-4310-a8d9-fb4dbda8d50b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bdb138c6-1c81-461f-adb8-b2f3f9047104" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bdb138c6-1c81-461f-adb8-b2f3f9047104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b60bcd37-3af3-4201-a93e-dc2438440ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis_bdb138c6-1c81-461f-adb8-b2f3f9047104" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersTypeDomain_b60bcd37-3af3-4201-a93e-dc2438440ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_0328174d-c74f-4148-a308-8ea684d709ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_us-gaap_TypeOfArrangementAxis_0328174d-c74f-4148-a308-8ea684d709ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_34457897-996f-459f-ae59-010573101f10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_0328174d-c74f-4148-a308-8ea684d709ea" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_34457897-996f-459f-ae59-010573101f10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_OneTimeUpfrontCashPaymentMember_4e53cee4-2d27-4be2-9ce6-ebce8a4d23f9" xlink:href="abus-20220331.xsd#abus_OneTimeUpfrontCashPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_34457897-996f-459f-ae59-010573101f10" xlink:to="loc_abus_OneTimeUpfrontCashPaymentMember_4e53cee4-2d27-4be2-9ce6-ebce8a4d23f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_96f9625f-efcb-4532-b39e-42c64cb8b1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_us-gaap_StatementClassOfStockAxis_96f9625f-efcb-4532-b39e-42c64cb8b1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7e45bc2-d73a-4c98-a491-d8fd755e40b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_96f9625f-efcb-4532-b39e-42c64cb8b1e0" xlink:to="loc_us-gaap_ClassOfStockDomain_d7e45bc2-d73a-4c98-a491-d8fd755e40b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_c2e6756c-e289-461c-8450-e7bf40ddad67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d7e45bc2-d73a-4c98-a491-d8fd755e40b8" xlink:to="loc_us-gaap_CommonStockMember_c2e6756c-e289-461c-8450-e7bf40ddad67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_90f4c022-18d7-46ca-b66a-e041d126204d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_OwnershipAxis_90f4c022-18d7-46ca-b66a-e041d126204d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_467f3744-12a1-4bc7-a3f8-b5433e152e7a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_90f4c022-18d7-46ca-b66a-e041d126204d" xlink:to="loc_srt_OwnershipDomain_467f3744-12a1-4bc7-a3f8-b5433e152e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_23d535f4-afe7-497f-9c89-66e80bbacb4c" xlink:href="abus-20220331.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_467f3744-12a1-4bc7-a3f8-b5433e152e7a" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_23d535f4-afe7-497f-9c89-66e80bbacb4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_481ff6fa-89a7-4f4e-aca8-7f410be4c48a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_srt_MajorCustomersAxis_481ff6fa-89a7-4f4e-aca8-7f410be4c48a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_43f98036-7cf3-4e69-a2da-57ec841afa24" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_481ff6fa-89a7-4f4e-aca8-7f410be4c48a" xlink:to="loc_srt_NameOfMajorCustomerDomain_43f98036-7cf3-4e69-a2da-57ec841afa24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_QiluPharmaceuticalCoLTDMember_2b530e44-508e-4f4c-a91e-5d45d324dcf2" xlink:href="abus-20220331.xsd#abus_QiluPharmaceuticalCoLTDMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_43f98036-7cf3-4e69-a2da-57ec841afa24" xlink:to="loc_abus_QiluPharmaceuticalCoLTDMember_2b530e44-508e-4f4c-a91e-5d45d324dcf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfResearchAndDevelopmentArrangementContractToPerformForOthersTable_5064b857-69b4-47b4-b58a-d264b0b5570c" xlink:to="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCostAndExpenseOperating_98341c46-45f3-46e8-ad98-e8ea06dc3d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCostAndExpenseOperating"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_OtherCostAndExpenseOperating_98341c46-45f3-46e8-ad98-e8ea06dc3d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyEntitlements_28d6bf9d-7efe-4cf7-9be2-d2e18e187fc0" xlink:href="abus-20220331.xsd#abus_RoyaltyEntitlements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyEntitlements_28d6bf9d-7efe-4cf7-9be2-d2e18e187fc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPercentageofInterestSold_3e4ebfb0-2c3d-43dc-bc14-d22735518457" xlink:href="abus-20220331.xsd#abus_RoyaltyPercentageofInterestSold"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyPercentageofInterestSold_3e4ebfb0-2c3d-43dc-bc14-d22735518457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_9aea46fa-a968-484b-a123-c1431140c862" xlink:href="abus-20220331.xsd#abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyInterestSoldPercentageOfSalesAnnualRevenueThresholdOfHighestTier_9aea46fa-a968-484b-a123-c1431140c862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GrossProceedsFromRoyaltyInterestSold_f54c6ce5-de64-4156-8f8f-1350f9963f75" xlink:href="abus-20220331.xsd#abus_GrossProceedsFromRoyaltyInterestSold"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_GrossProceedsFromRoyaltyInterestSold_f54c6ce5-de64-4156-8f8f-1350f9963f75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_5367945b-ec45-403d-a9f8-0e10a12c0f62" xlink:href="abus-20220331.xsd#abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyInterestSoldMaximumRoyaltiesForBuyer_5367945b-ec45-403d-a9f8-0e10a12c0f62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_463fbb05-3014-4805-8829-61d40338ff49" xlink:href="abus-20220331.xsd#abus_RoyaltyGuaranteesCommitmentsPercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyGuaranteesCommitmentsPercentage_463fbb05-3014-4805-8829-61d40338ff49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoyaltyPayable_2c53430f-940e-4a45-acf5-af73399123a0" xlink:href="abus-20220331.xsd#abus_RoyaltyPayable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_RoyaltyPayable_2c53430f-940e-4a45-acf5-af73399123a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_11e7b218-b927-4cb2-89dc-119c1e864189" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_Revenues_11e7b218-b927-4cb2-89dc-119c1e864189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PotentialMilestonePayments_af3fc3b5-8279-410d-95e0-c98400a94e53" xlink:href="abus-20220331.xsd#abus_PotentialMilestonePayments"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_PotentialMilestonePayments_af3fc3b5-8279-410d-95e0-c98400a94e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromCollaborators_8e4c31e8-a011-463c-b944-e9228e9a2296" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromCollaborators"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_ProceedsFromCollaborators_8e4c31e8-a011-463c-b944-e9228e9a2296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_83a46b03-4017-4bf2-8eb1-482329d1db41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_CommonStockSharesIssued_83a46b03-4017-4bf2-8eb1-482329d1db41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_3b5438eb-c8b2-4d82-846f-8b6e369e5518" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_SharePrice_3b5438eb-c8b2-4d82-846f-8b6e369e5518" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4d71ddf9-2f5c-4726-82f2-8adbea264902" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_4d71ddf9-2f5c-4726-82f2-8adbea264902" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_3c098d42-97aa-4eeb-90ab-6dccdd62f3fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners_3c098d42-97aa-4eeb-90ab-6dccdd62f3fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecoveryOfDirectCosts_605f5772-a055-4f8d-b931-129e4269d962" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RecoveryOfDirectCosts"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_RecoveryOfDirectCosts_605f5772-a055-4f8d-b931-129e4269d962" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1c472491-8cfa-466b-93dc-955e6b69f338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1c472491-8cfa-466b-93dc-955e6b69f338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_58f83bf5-cfcc-499e-8eaa-d0738537a5de" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_DeferredRevenueCurrent_58f83bf5-cfcc-499e-8eaa-d0738537a5de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_baef82a2-1c58-48eb-9e93-63d9955a5f71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_baef82a2-1c58-48eb-9e93-63d9955a5f71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_465092ab-6ba0-44fb-9243-8c1dd08b4565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_IncomeTaxesPaid_465092ab-6ba0-44fb-9243-8c1dd08b4565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_960e93c2-e825-4f4e-9998-235be2db0dbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_960e93c2-e825-4f4e-9998-235be2db0dbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherDeferredCostsGross_f72c6b92-3ff6-434e-acd2-456c45a39705" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherDeferredCostsGross"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_OtherDeferredCostsGross_f72c6b92-3ff6-434e-acd2-456c45a39705" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PremiumonClosingStockPrice_027fd74f-6082-4192-83b3-d59b685b61c5" xlink:href="abus-20220331.xsd#abus_PremiumonClosingStockPrice"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_PremiumonClosingStockPrice_027fd74f-6082-4192-83b3-d59b685b61c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_46b96a10-ecd5-41e4-a3a6-e4f7ee1b8515" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_46b96a10-ecd5-41e4-a3a6-e4f7ee1b8515" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_c4c345fb-ead1-4f2a-aeb0-d3d3f509b61d" xlink:href="abus-20220331.xsd#abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_abus_NonCashRoyaltyRevenueRelatedToSaleOfFutureRoyalties_c4c345fb-ead1-4f2a-aeb0-d3d3f509b61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PremiumsEarnedNet_31b49e04-90a0-4665-9ada-8545934ba4bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PremiumsEarnedNet"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems_80294ed4-b659-4bbc-92c9-5eac1a3a39e6" xlink:to="loc_us-gaap_PremiumsEarnedNet_31b49e04-90a0-4665-9ada-8545934ba4bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Shareholdersequity" xlink:type="simple" xlink:href="abus-20220331.xsd#Shareholdersequity"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Shareholdersequity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_cb80b246-f53e-412a-9c5b-46ac39f4f9c2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7bd35e4e-0580-463b-b031-d9783827ac93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_cb80b246-f53e-412a-9c5b-46ac39f4f9c2" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_7bd35e4e-0580-463b-b031-d9783827ac93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityTables" xlink:type="simple" xlink:href="abus-20220331.xsd#ShareholdersequityTables"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_8f4448a3-5048-4359-8359-a9ef6375738d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c74dbdf5-938c-4add-8bbc-6c1983a9893b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_8f4448a3-5048-4359-8359-a9ef6375738d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_c74dbdf5-938c-4add-8bbc-6c1983a9893b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityNarrativeDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#ShareholdersequityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_a42f4fb6-ac74-4049-a5de-c56d5483bca2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_a42f4fb6-ac74-4049-a5de-c56d5483bca2" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_2afddf6d-f063-4be6-94ba-a4cfc67835ad" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:to="loc_srt_CounterpartyNameAxis_2afddf6d-f063-4be6-94ba-a4cfc67835ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7543b30e-07e6-4fb5-96e5-5c6db215a968" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_2afddf6d-f063-4be6-94ba-a4cfc67835ad" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7543b30e-07e6-4fb5-96e5-5c6db215a968" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_JefferiesLLCMember_407550d5-75f6-4f0c-9c66-324ee332b949" xlink:href="abus-20220331.xsd#abus_JefferiesLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7543b30e-07e6-4fb5-96e5-5c6db215a968" xlink:to="loc_abus_JefferiesLLCMember_407550d5-75f6-4f0c-9c66-324ee332b949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RoivantSciencesLtdMember_c742e745-8eb3-4834-91f0-6d90ab8acffa" xlink:href="abus-20220331.xsd#abus_RoivantSciencesLtdMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_7543b30e-07e6-4fb5-96e5-5c6db215a968" xlink:to="loc_abus_RoivantSciencesLtdMember_c742e745-8eb3-4834-91f0-6d90ab8acffa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_41f2b374-7b2d-41f5-ae13-87da8b8fc028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_41f2b374-7b2d-41f5-ae13-87da8b8fc028" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_7ce44a5a-cc40-4200-ad63-7d77c67a718b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_41f2b374-7b2d-41f5-ae13-87da8b8fc028" xlink:to="loc_us-gaap_ClassOfStockDomain_7ce44a5a-cc40-4200-ad63-7d77c67a718b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_8c337de4-dc65-44cb-b6c4-4fa2185985aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7ce44a5a-cc40-4200-ad63-7d77c67a718b" xlink:to="loc_us-gaap_CommonStockMember_8c337de4-dc65-44cb-b6c4-4fa2185985aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_3d5fea4c-d506-49f7-bdd1-da03924b4a35" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_7ce44a5a-cc40-4200-ad63-7d77c67a718b" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_3d5fea4c-d506-49f7-bdd1-da03924b4a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_33b2a9a9-c11f-4173-ac59-3b39ae734d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_33b2a9a9-c11f-4173-ac59-3b39ae734d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_33b2a9a9-c11f-4173-ac59-3b39ae734d3a" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_A2019AmendedSaleAgreementMember_7978ebfa-461d-46d4-bc5e-50f9a6d89499" xlink:href="abus-20220331.xsd#abus_A2019AmendedSaleAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_A2019AmendedSaleAgreementMember_7978ebfa-461d-46d4-bc5e-50f9a6d89499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020RegistrationStmtMember_7c2e66ca-b75d-4f65-906b-b1b9ca92aada" xlink:href="abus-20220331.xsd#abus_Jan2020RegistrationStmtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Jan2020RegistrationStmtMember_7c2e66ca-b75d-4f65-906b-b1b9ca92aada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020ProspectusSupplementAgreementMember_5b2008c6-9437-4713-8e73-ddd386e2bf06" xlink:href="abus-20220331.xsd#abus_Jan2020ProspectusSupplementAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Jan2020ProspectusSupplementAgreementMember_5b2008c6-9437-4713-8e73-ddd386e2bf06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_SaleAgreementMember_6cf78e70-6434-4f1c-a0c0-5f49a2903e00" xlink:href="abus-20220331.xsd#abus_SaleAgreementMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_SaleAgreementMember_6cf78e70-6434-4f1c-a0c0-5f49a2903e00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Oct2020RegistrationStmtMember_c047ecca-6891-4817-a112-44ee8bb85e8c" xlink:href="abus-20220331.xsd#abus_Oct2020RegistrationStmtMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Oct2020RegistrationStmtMember_c047ecca-6891-4817-a112-44ee8bb85e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Mar2021ProspectusSupplementAgreementMember_86507bb0-b222-4090-9d3d-6e028ba680a3" xlink:href="abus-20220331.xsd#abus_Mar2021ProspectusSupplementAgreementMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Mar2021ProspectusSupplementAgreementMember_86507bb0-b222-4090-9d3d-6e028ba680a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_October2021ProspectusSupplementMember_516aec8d-8384-47a4-8995-cb0143c966ed" xlink:href="abus-20220331.xsd#abus_October2021ProspectusSupplementMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_October2021ProspectusSupplementMember_516aec8d-8384-47a4-8995-cb0143c966ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_March2022ProspectusSupplementMember_e8a315b2-624a-401d-9451-9dc6b95791e6" xlink:href="abus-20220331.xsd#abus_March2022ProspectusSupplementMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_March2022ProspectusSupplementMember_e8a315b2-624a-401d-9451-9dc6b95791e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020ProspectusSupplementMember_5165d029-a6ee-429b-acc3-df70fb8a32fc" xlink:href="abus-20220331.xsd#abus_Jan2020ProspectusSupplementMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Jan2020ProspectusSupplementMember_5165d029-a6ee-429b-acc3-df70fb8a32fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Aug2020ProspectusSupplementMember_abc21dbf-2584-40b1-85e2-0536d1d0c9ec" xlink:href="abus-20220331.xsd#abus_Aug2020ProspectusSupplementMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_0d817219-fef9-4622-a627-bf4b1d0e1de3" xlink:to="loc_abus_Aug2020ProspectusSupplementMember_abc21dbf-2584-40b1-85e2-0536d1d0c9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RegistrationStatementAxis_ac504ffe-690e-4610-b40c-523203ba4a7a" xlink:href="abus-20220331.xsd#abus_RegistrationStatementAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:to="loc_abus_RegistrationStatementAxis_ac504ffe-690e-4610-b40c-523203ba4a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_RegistrationStatementDomain_0bf168d1-d841-46c8-8832-fb93f4a8ca7c" xlink:href="abus-20220331.xsd#abus_RegistrationStatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementAxis_ac504ffe-690e-4610-b40c-523203ba4a7a" xlink:to="loc_abus_RegistrationStatementDomain_0bf168d1-d841-46c8-8832-fb93f4a8ca7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020RegistrationStmtMember_090de930-0801-45b3-9ec2-0dd456a394d5" xlink:href="abus-20220331.xsd#abus_Jan2020RegistrationStmtMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_0bf168d1-d841-46c8-8832-fb93f4a8ca7c" xlink:to="loc_abus_Jan2020RegistrationStmtMember_090de930-0801-45b3-9ec2-0dd456a394d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Oct2020RegistrationStmtMember_371e3f36-864c-4184-8668-95497f8e0406" xlink:href="abus-20220331.xsd#abus_Oct2020RegistrationStmtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_0bf168d1-d841-46c8-8832-fb93f4a8ca7c" xlink:to="loc_abus_Oct2020RegistrationStmtMember_371e3f36-864c-4184-8668-95497f8e0406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember_2b80024e-7d04-464a-baa5-e2cd24137238" xlink:href="abus-20220331.xsd#abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_abus_RegistrationStatementDomain_0bf168d1-d841-46c8-8832-fb93f4a8ca7c" xlink:to="loc_abus_Jan2020Oct2020AndNov2021RegistrationStmtsMember_2b80024e-7d04-464a-baa5-e2cd24137238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_b384a972-1aa8-4f78-963c-d9b1cd0e5ea5" xlink:to="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesSubscriptions_b480f6cc-2a62-41a5-a721-625dc89efbca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesSubscriptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_CommonStockSharesSubscriptions_b480f6cc-2a62-41a5-a721-625dc89efbca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_c195d87b-73b0-40f9-99b5-458568906fa0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_c195d87b-73b0-40f9-99b5-458568906fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0210c862-4ce9-42cf-9360-e98a6b56b565" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_0210c862-4ce9-42cf-9360-e98a6b56b565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_46cf7801-7305-4914-843b-408ed1fd1e49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_46cf7801-7305-4914-843b-408ed1fd1e49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4db02a4a-a9ab-4e1c-acf6-0e159c7bf14a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_4db02a4a-a9ab-4e1c-acf6-0e159c7bf14a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_PremiumonClosingStockPrice_fa1c6fc8-47e4-40ca-bdbe-c8db39211ca7" xlink:href="abus-20220331.xsd#abus_PremiumonClosingStockPrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_abus_PremiumonClosingStockPrice_fa1c6fc8-47e4-40ca-bdbe-c8db39211ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5b230bd9-a0a8-4602-a7aa-b30fdd397ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_SharePrice_5b230bd9-a0a8-4602-a7aa-b30fdd397ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockDividendRatePercentage_a9595778-35b3-45c6-a6b6-0eb96d5e856e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockDividendRatePercentage"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_PreferredStockDividendRatePercentage_a9595778-35b3-45c6-a6b6-0eb96d5e856e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_468eb412-5d66-4800-85dd-894c9eb7ee62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_468eb412-5d66-4800-85dd-894c9eb7ee62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_6bf42ecd-d9d7-4ebf-ad22-a315daa4d954" xlink:href="abus-20220331.xsd#abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_abus_NoncontrollingInterestOwnershipPercentageByNoncontrollingOwnersAfterConversion_6bf42ecd-d9d7-4ebf-ad22-a315daa4d954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_f490a809-cadc-4af2-92c6-e860a01af07e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_94ab6ce0-0bc8-46d4-bab1-dc6886419a04" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_f490a809-cadc-4af2-92c6-e860a01af07e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/ShareholdersequityStockbasedCompensationDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#ShareholdersequityStockbasedCompensationDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/ShareholdersequityStockbasedCompensationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_7c485d0a-7bdd-4beb-aee8-39b2a591b385" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_944c68ac-1f08-4e0a-98af-6b31cf4146c8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_7c485d0a-7bdd-4beb-aee8-39b2a591b385" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_944c68ac-1f08-4e0a-98af-6b31cf4146c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f73e25c8-ca8a-4e00-98d3-a2893236faad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_944c68ac-1f08-4e0a-98af-6b31cf4146c8" xlink:to="loc_us-gaap_PlanNameAxis_f73e25c8-ca8a-4e00-98d3-a2893236faad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_41fd56e6-b9d0-4710-89f5-3dc75bfb6d26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f73e25c8-ca8a-4e00-98d3-a2893236faad" xlink:to="loc_us-gaap_PlanNameDomain_41fd56e6-b9d0-4710-89f5-3dc75bfb6d26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ArbutusPlansMember_520fb115-63a9-424a-8a4a-c1bd801304c3" xlink:href="abus-20220331.xsd#abus_ArbutusPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_41fd56e6-b9d0-4710-89f5-3dc75bfb6d26" xlink:to="loc_abus_ArbutusPlansMember_520fb115-63a9-424a-8a4a-c1bd801304c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_cf3fc62e-4ab5-4669-8b56-b160ccc633fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_944c68ac-1f08-4e0a-98af-6b31cf4146c8" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_cf3fc62e-4ab5-4669-8b56-b160ccc633fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_62ce5ee9-67ce-4a3d-a58a-696688f16903" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_cf3fc62e-4ab5-4669-8b56-b160ccc633fc" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_62ce5ee9-67ce-4a3d-a58a-696688f16903" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5acaba0d-3537-474c-a826-78ea52398d92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_62ce5ee9-67ce-4a3d-a58a-696688f16903" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_5acaba0d-3537-474c-a826-78ea52398d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d5db18a8-c05e-49c5-9bf6-78760e237dca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_62ce5ee9-67ce-4a3d-a58a-696688f16903" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_d5db18a8-c05e-49c5-9bf6-78760e237dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58aea7ec-9789-44d8-8c02-23e69cae9c48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_944c68ac-1f08-4e0a-98af-6b31cf4146c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58aea7ec-9789-44d8-8c02-23e69cae9c48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_039cccc9-d47a-4c2a-8056-ff9bb1edd8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58aea7ec-9789-44d8-8c02-23e69cae9c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_039cccc9-d47a-4c2a-8056-ff9bb1edd8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d28c4f0d-8c83-40a6-8596-60afdc81e52b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58aea7ec-9789-44d8-8c02-23e69cae9c48" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d28c4f0d-8c83-40a6-8596-60afdc81e52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_6a960206-c7e8-4b77-b8ea-012972285c12" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_58aea7ec-9789-44d8-8c02-23e69cae9c48" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_6a960206-c7e8-4b77-b8ea-012972285c12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/Relatedpartytransactions" xlink:type="simple" xlink:href="abus-20220331.xsd#Relatedpartytransactions"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/Relatedpartytransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_551aef25-f4e4-4275-ab68-63883695224d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e0950013-aa63-4f28-8243-22ab7f827bca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_551aef25-f4e4-4275-ab68-63883695224d" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_e0950013-aa63-4f28-8243-22ab7f827bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://arbutusbio.com/role/RelatedpartytransactionsDetails" xlink:type="simple" xlink:href="abus-20220331.xsd#RelatedpartytransactionsDetails"/>
  <link:presentationLink xlink:role="http://arbutusbio.com/role/RelatedpartytransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_5b7e3fa7-2614-43bc-ab7f-5f6105003d22" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5c468b53-9e9c-4fb3-aa62-b156a3d09b39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_5b7e3fa7-2614-43bc-ab7f-5f6105003d22" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5c468b53-9e9c-4fb3-aa62-b156a3d09b39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_502194ce-7006-440f-a635-e17b041fc5ae" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5c468b53-9e9c-4fb3-aa62-b156a3d09b39" xlink:to="loc_srt_CounterpartyNameAxis_502194ce-7006-440f-a635-e17b041fc5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d68e3d0-a85b-4a28-99f9-6925d86ed0d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_502194ce-7006-440f-a635-e17b041fc5ae" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d68e3d0-a85b-4a28-99f9-6925d86ed0d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_GenevantSciencesCorporationMember_d19c0b7f-4818-4631-9733-c52882e79d98" xlink:href="abus-20220331.xsd#abus_GenevantSciencesCorporationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_9d68e3d0-a85b-4a28-99f9-6925d86ed0d9" xlink:to="loc_abus_GenevantSciencesCorporationMember_d19c0b7f-4818-4631-9733-c52882e79d98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_ab8f5357-dd55-4e7d-8e70-a90c8989fbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5c468b53-9e9c-4fb3-aa62-b156a3d09b39" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_ab8f5357-dd55-4e7d-8e70-a90c8989fbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_71256563-5988-49bb-9a2b-0ecd09d43cd3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_ab8f5357-dd55-4e7d-8e70-a90c8989fbc1" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_71256563-5988-49bb-9a2b-0ecd09d43cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_abus_ResearchAndDevelopmentServicesMember_c5f57f73-344c-475c-9762-0f2dfe776e47" xlink:href="abus-20220331.xsd#abus_ResearchAndDevelopmentServicesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_71256563-5988-49bb-9a2b-0ecd09d43cd3" xlink:to="loc_abus_ResearchAndDevelopmentServicesMember_c5f57f73-344c-475c-9762-0f2dfe776e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_ce38348e-a448-42f5-9215-32bb1f343d19" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_5c468b53-9e9c-4fb3-aa62-b156a3d09b39" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_ce38348e-a448-42f5-9215-32bb1f343d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c7abb016-c238-4b49-8eff-0e4eb0efab18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_ce38348e-a448-42f5-9215-32bb1f343d19" xlink:to="loc_us-gaap_RelatedPartyTransactionOtherRevenuesFromTransactionsWithRelatedParty_c7abb016-c238-4b49-8eff-0e4eb0efab18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
